MedDataX Logo

An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia

NCT ID: NCT01206231

Last Updated: 2011-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

330 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-12-31

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is aimed to collect the following Serbia-specific epidemiology data on hypercholesterolemia: patents characteristics, patients' management/treatment and physicians' standard practice. In addition, the aim is to determine the proportion of patients on lipid-lowering pharmacological treatment who have reached the LDL-C and HDL-C treatment goals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercholesterolemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Patients with hypercholesterolemia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with hypercholesterolemia currently receiving a lipid lowering agent

Exclusion Criteria

* Pregnancy and lactation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Prof.Dr Miodrag Ostojic

Role: PRINCIPAL_INVESTIGATOR

Division of Cardiology-Clinical Centre of Serbia-Belgrade

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Belgrade, , Serbia

Site Status

Research Site

Čačak, , Serbia

Site Status

Research Site

Kamenitz, , Serbia

Site Status

Research Site

Kragujevac, , Serbia

Site Status

Research Site

Niš, , Serbia

Site Status

Research Site

Niška Banja, , Serbia

Site Status

Research Site

Pančevo, , Serbia

Site Status

Research Site

Požarevac, , Serbia

Site Status

Research Site

Sombor, , Serbia

Site Status

Research Site

Užice, , Serbia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Serbia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-CRS-DUM-2010/1

Identifier Type: -

Identifier Source: org_study_id